SUCCESSFUL SALVAGE THERAPY OF RESISTANT GESTATIONAL TROPHOBLASTIC DISEASE WITH ETOPOSIDE, METHOTREXATE, DACTINOMYCIN, VINCRISTINE, AND CYCLOPHOSPHAMIDE

被引：2
|
作者：
GALLION, HH [1 ]
VANNAGELL, JR [1 ]
DONALDSON, ES [1 ]
HIGGINS, RV [1 ]
机构：
[1] UNIV KENTUCKY,MED CTR,DEPT OBSTET & GYNECOL,LEXINGTON,KY 40536
来源：
GYNECOLOGIC ONCOLOGY | 1989年 / 34卷 / 01期
关键词：
D O I：
10.1016/0090-8258(89)90116-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：98 / 100
页数：3
相关论文
共 50 条
  • [1] Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP)
    Bilgin T.
    Ozan H.
    Özuysal S.
    Özkan L.
    [J]. Archives of Gynecology and Obstetrics, 2004, 269 (2) : 159 - 160
  • [2] ALTERNATING WEEKLY CHEMOTHERAPY WITH ETOPOSIDE-METHOTREXATE-DACTINOMYCIN CYCLOPHOSPHAMIDE-VINCRISTINE FOR HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE
    SOPER, JT
    EVANS, AC
    CLARKEPEARSON, DL
    BERCHUCK, A
    RODRIGUEZ, G
    HAMMOND, CB
    [J]. OBSTETRICS AND GYNECOLOGY, 1994, 83 (01): : 113 - 117
  • [3] Conservative Chemotherapy in Gestational Trophoblastic Disease Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy
    Byun, Seung Won
    Park, Tae Chul
    Bae, Seog Nyeon
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (04) : 790 - 795
  • [4] M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia
    Singh, Kam
    Gillett, Sarah
    Ireson, Jane
    Hills, Anne
    Tidy, John A.
    Coleman, Robert E.
    Hancock, Barry W.
    Winter, Matthew C.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (09) : 2335 - 2344
  • [5] Successful salvage therapy of resistant gestational trophoblastic disease with ifosfamide and paclitaxel
    Shorbagi, A
    Aksoy, S
    Kilickap, S
    Güler, N
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 722 - 723
  • [6] Serum human chorionic gonadotropin ratios for the detection of etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine resistance in high-risk gestational trophoblastic neoplasia
    Sirimusika, Nathapol
    Boonyapipat, Sathana
    [J]. HEALTH SCIENCE REPORTS, 2022, 5 (04)
  • [7] Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia
    Feng, F.
    Xiang, Y.
    Wan, X.
    Geng, S.
    Wang, T.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (07) : 1588 - 1594
  • [8] ALTERNATING METHOTREXATE AND DACTINOMYCIN IN NONMETASTATIC GESTATIONAL TROPHOBLASTIC DISEASE
    ROSE, PG
    PIVER, MS
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1989, 41 (03) : 148 - 152
  • [9] ETOPOSIDE, METHOTREXATE, ACTINOMYCIN-D, CYCLOPHOSPHAMIDE, AND VINCRISTINE FOR THE TREATMENT OF METASTATIC, HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE
    SCHINK, JC
    SINGH, DK
    RADEMAKER, AW
    MILLER, DS
    LURAIN, JR
    [J]. OBSTETRICS AND GYNECOLOGY, 1992, 80 (05): : 817 - 820
  • [10] ETOPOSIDE, METHOTREXATE, AND BLEOMYCIN IN DRUG-RESISTANT GESTATIONAL TROPHOBLASTIC DISEASE
    WONG, LC
    CHOO, YC
    MA, HK
    [J]. GYNECOLOGIC ONCOLOGY, 1986, 24 (01) : 51 - 57
12345